Active Ingredient(s): Clofarabine
FDA Approved: * December 28, 2004
Pharm Company: * GENZYME
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Clolar Overview

Clofarabine is a purine nucleoside antimetabolite marketed in the United States and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under the name Evoltra. It is FDA-approved for treating relapsed or refractory acute lymphoblastic leukaemia (ALL) in children after at least two other types of treatment have failed. Some investigations of effectiveness in cases of acute myeloid leukaemia (AML) and juvenile myelomonocytic leukaemia (JMML) have been carried out. Ong...

Read more Clolar Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Clolar Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 1mg/ml, 20mg/20ml, 20mg/20ml (1mg/ml)
  • Solution: 20mg/20ml (1mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Clolar: (3 results)

Sorted by National Drug Code
  • 0024-5860 Clolar 1 mg/ml Intravenous Injection by Sanofi-aventis U.S. LLC
  • 0024-5917 Clolar 1 mg/ml Intravenous Injection by Sanofi-aventis U.S. LLC
  • 58468-0100 Clolar 1 mg/ml Intravenous Injection by Genzyme Corporation

Other drugs which contain Clofarabine or a similar ingredient: (1 result)